F. P. Siegal, N. Kadowaki, M. Shodell, P. A. Fitzgerald-bocarsly, K. Shah et al., The nature of the principal type 1 interferon-producing cells in human blood, Science, vol.284, pp.1835-1842, 1999.

Y. J. Liu, IPC: professional type 1 interferon-producing cells 2. and plasmacytoid dendritic cell precursors, Annu Rev Immunol, vol.23, pp.275-306, 2005.

M. Cella, F. Facchetti, A. Lanzavecchia, and M. Colonna, Plasmacy-3. toid dendritic cells activated by infl uenza virus and CD40L drive a potent TH1 polarization, Nat Immunol, vol.1, pp.305-315, 2000.

J. F. Fonteneau, M. Larsson, A. S. Beignon, K. Mckenna, and . Dasilva-4,

I. and A. A. , Human immunodefi ciency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells, J Virol, vol.78, pp.5223-5255, 2004.

J. F. Fonteneau, M. Gilliet, M. Larsson, I. Dasilva, C. Munz et al.,

. Yj, Activation of infl uenza virus-specifi c CD4 ? and CD8 ? T cells: a new role for plasmacytoid dendritic cells in adaptive immunity, Blood, vol.101, pp.3520-3526, 2003.

G. Hoeffel, A. C. Ripoche, D. Matheoud, M. Nascimbeni, E. 6. Lebon et al., Antigen crosspresentation by human plasmacytoid dendritic cells, Immunity, vol.27, pp.481-92, 2007.
URL : https://hal.archives-ouvertes.fr/pasteur-00360697

J. Bauer, Advances in cell separation: recent developments in 7. counterfl ow centrifugal elutriation and continuous fl ow cell separation, J Chromatogr B Biomed Sci Appl, vol.722, pp.55-69, 1999.

L. M. Wahl, S. M. Wahl, L. E. Smythies, and P. D. Smith, Isolation of 8. human monocyte populations, Curr Protoc Immunol, vol.7, p.6, 2006.

T. G. Berger, E. Strasser, R. Smith, C. Carste, and . Schuler-thurner,

B. and K. E. , Vrielink H, Marieke van Ham S. Generation of dendritic cells for immunotherapy is minimally impaired by granulocytes in the monocyte preparation, Immunobiology, vol.14, pp.633-673, 2006.

C. Guiducci, G. Ott, J. H. Chan, E. Damon, C. Calacsan et al.,

T. , Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation, J Exp Med, vol.203, pp.1999-2008, 2006.

A. Dzionek, A. Fuchs, P. Schmidt, S. Cremer, M. Zysk et al.,

S. , BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood, J Immunol, vol.165, pp.6037-6083, 2000.

J. H. Gerrits, P. Athanassopoulos, L. M. Vaessen, and M. Klepper, Wei-17. mar W, van Besouw NM. Peripheral blood manipulation signifi cantly affects the result of dendritic cell monitoring, Transpl Immunol, vol.17, pp.169-77, 2007.

, within a closed system (Elutra) for clinical-scale generation of dendritic cells, J Immunol Methods, vol.298, pp.61-72, 2005.

D. J. Powell, A. L. Brennan, Z. Zheng, H. Huynh, J. Cotte et al.,

. Bl, Effi cient clinical-scale enrichment of lymphocytes for use in adoptive immunotherapy using a modifi ed counterfl ow centrifugal elutriation program, Cytotherapy, vol.11, pp.923-958, 2009.

K. P. Micklethwaite, F. M. Garvin, M. R. Kariotis, Y. Ll, . Hansen-11 et al., Clinical-scale elutriation as a means of enriching antigen-presenting cells and manipulating alloreactivity, Cytotherapy, vol.11, pp.218-246, 2009.

R. L. Eifl-er, J. Lind, D. Falkenhagen, V. Weber, and M. B. Fischer, Zeill-12. inger R. Enrichment of circulating tumor cells from a large blood volume using leukapheresis and elutriation: proof of concept, Cytometry B Clin Cytom, vol.80, pp.100-111, 2011.

C. Auffray, M. H. Sieweke, and F. Geissmann, Blood monocytes: 13. development, heterogeneity, and relationship with dendritic cells, Annu Rev Immunol, vol.27, pp.669-92, 2009.